TrialJournal of psychiatric research2023

Pilot study of single-dose psilocybin for serotonin reuptake inhibitor-resistant body dysmorphic disorder.

Franklin R Schneier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.